Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group
Authors:
- John A. BlessingJBJohn A. Blessing
- Guy BoikeGBGuy Boike
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (1) , 64-66
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1997
- Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical ReversalPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1996
- Pentoxifylline Potentiates the Antitumor Effect of Cisplatin and Etoposide on Human Lung Cancer Cell LinesOncology, 1996
- A phase I study of escalating dose trental with cisplatin in advanced or recurrent gynecologic cancer: A chemomodulation regimenGynecologic Oncology, 1992
- Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell lineGynecologic Oncology, 1990
- A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group studyGynecologic Oncology, 1989
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985